SMAD7 and cancer: In HUVECs, miR-27b-3p not only suppressed cell proliferation and migration via Smad7-mediated modification of TGF-β but also sensitized breast cancer cells to several anti-cancer treatments both in vivo and in vitro, suggesting the probable involvement of miR-27b-3p in cancer biology (127).